Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350 - Investorplace.com

1. Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350  Investorplace.com
2. J&J says its one-shot Covid-19 vaccine is 72% effective in the U.S.  CNBC Television
3. Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa  The New York Times
4. Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19  NPR
5. Covid live updates: Major Canadian airlines suspend flights to warm destinations to slow spread  CNBC
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3taFe3C
via IFTTT